Cargando…

NDRG1 in Cancer: A Suppressor, Promoter, or Both?

SIMPLE SUMMARY: NDRG1 (N-myc downregulated gene-1) has been reported to suppress metastasis, to be a biomarker of poor outcome, and to be a facilitator of disease progression in a range of different cancers. Characterizing NDRG1 remains challenging due to its pleiotropic functions. This review summa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Vaibhavi, Lakhani, Sunil R., McCart Reed, Amy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737586/ https://www.ncbi.nlm.nih.gov/pubmed/36497221 http://dx.doi.org/10.3390/cancers14235739

Ejemplares similares

A Molecular and Morphological Deep-Dive Into Metaplastic Breast Cancers
por: McCart Reed, Amy E, et al.
Publicado: (2019)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
por: Feng, Yufan, et al.
Publicado: (2023)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Editorial: Molecular mechanisms in breast cancer progression and metastasis
por: Fedele, Monica, et al.
Publicado: (2022)

Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development
por: Kondrashova, Olga, et al.
Publicado: (2021)

Oncogenic MNK signalling regulates the metastasis suppressor NDRG1
por: Tian, Shuye, et al.
Publicado: (2017)

Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1
por: Chang, Jiawei, et al.
Publicado: (2023)

The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer
por: Lim, Syer C., et al.
Publicado: (2021)

Toothache of Horses
por: McCart, T. S.
Publicado: (1887)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling
por: Mungunsukh, Ognoon, et al.
Publicado: (2014)

A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas
por: Nakahara, Yukiko, et al.
Publicado: (2022)

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Metastatic progression of breast cancer: insights from 50 years of autopsies
por: Cummings, Margaret C, et al.
Publicado: (2014)

N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor
por: Kim, Gayeon, et al.
Publicado: (2021)

The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
por: Sharma, Anup, et al.
Publicado: (2017)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

Ndrg1 promotes adipocyte differentiation and sustains their function
por: Cai, Kai, et al.
Publicado: (2017)

A review on the role of NDRG1 in different cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2023)

The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells
por: Mi, L, et al.
Publicado: (2017)

The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells
por: Lin, Hsin-Chen, et al.
Publicado: (2017)

The Metastasis Suppressor, N-myc Downregulated Gene 1 (NDRG1), Is a Prognostic Biomarker for Human Colorectal Cancer
por: Mao, Zhihai, et al.
Publicado: (2013)

The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1
por: Liu, Wensheng, et al.
Publicado: (2015)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1
por: Lee, Jae Eun, et al.
Publicado: (2015)

Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer via down-regulation of nuclear β-catenin and CD44
por: Wangpu, Xiongzhi, et al.
Publicado: (2015)

Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer
por: Shen, L, et al.
Publicado: (2014)

Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
por: Xu, Xinyuan, et al.
Publicado: (2015)

NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients
por: Chu, Dake, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m9borauibbu50qq4up1vsuqsf9